Comparison the effect of dexmetedomidin, magnesium sulfate and osmolol for ?hypotension control in patients who are candidate for craniotomy surgery ?because of head injury

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N86

Enrollment

Registered

2018-10-07

Start date

2018-02-20

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniotomy. Superficial injury of head

Interventions

Intervention 1: Intervention group: We inject 1 milligram in kilogram Dexmedetomidin in Dexmedetomidin group as loading dose and after Intubation we inject 0/5 milligram in kilogram in hours Dexmedeto

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Craniotomy candidate both of gender

Exclusion criteria

Exclusion criteria: Dissatisfaction

Design outcomes

Primary

Measure	Time frame
Heart rate. Timepoint: Every 15 minutes until the end of surgery. Method of measurement: Count.;Blood pressure. Timepoint: Every 15 minutes until the end of surgery. Method of measurement: Barometer.;Bleeding. Timepoint: Every 15 minutes until the end of surgery. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026